Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Hypomyelination with atrophy of the basal ganglia and cerebellum. Contribution of two new cases to a recently reported entity].
Safety of TNF inhibitors in adolescents and children.
Gallic acid-based small-molecule inhibitors of JC and BK polyomaviral infection.
Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis.
Mouse Models of Multiple Sclerosis: Experimental Autoimmune Encephalomyelitis and Theiler's Virus-Induced Demyelinating Disease.
Alterations of juxtaparanodal domains in two rodent models of CNS demyelination.
Alternative data sources for estimating multiple sclerosis prevalence.
Subcutaneous IgG in neurologic diseases.
Differentiation of neuromyelitis optica from multiple sclerosis in a cohort from the mainland of China.
Melatonin treatment improves primary progressive multiple sclerosis: a case report.
Dickkopf-3, a tissue-derived modulator of local T-cell responses.
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
Neurovascular and Immuno-Imaging: From Mechanisms to Therapies. Proceedings of the Inaugural Symposium.
Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
Effects of fatigue on balance and mobility in subjects with multiple sclerosis: a brief report.
Preventive treatment with methylprednisolone paradoxically exacerbates experimental autoimmune encephalomyelitis.
Confounding Parameters in Pre-clinical Assessment of Blood-brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States.
Clinical prospective study of visual function in patients with acute optic neuritis.
Elevation of Tumor Necrosis Factor Alpha in Dorsal Root Ganglia and Spinal Cord is Associated with Neuroimmune Modulation of Pain in an Animal Model of Multiple Sclerosis.
Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal.
Clinically isolated syndrome manifested as acute vestibular syndrome: Bedside neuro-otological examination and suppression of transient evoked otoacoustic emissions in the differential diagnosis.
Literature Commentary.
Guillain-Barre Syndrome After Robotically Assisted Laparoscopic Prostatectomy: First Case Report.
Anti-MOG antibodies are under polygenic regulation with the most significant control coming from the C-type lectin-like gene locus.
Investigation of cytocrom c oxidase gene subunits expression on the Multiple sclerosis.
Pages
« first
‹ previous
…
426
427
428
429
430
431
432
433
434
…
next ›
last »